Harmony Biosciences Holdings, I (HRMY)

Pharmaceuticals

HRMY · NASDAQ NMS - GLOBAL MARKET · USD

New to investing? How to read this page →

$38.81

+4.86%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$2.71

ROE

17.9%

Gross margin

76.5%

Debt/Equity

0.18x

Revenue growth

16.6%

Harmony Biosciences Holdings, I — company intelligence

Earnings surprises

Q1 2026$0.55 vs $0.71 est-22.3%

Q4 2025$0.38 vs $0.91 est-58.4%

Q3 2025$0.87 vs $0.86 est+1.6%

Q2 2025$0.68 vs $0.77 est-11.2%

Analyst consensus · 17 analysts

11 Buy5 Hold1 Sell

Updated Jul 6, 2026

Insider activity · 90 days

7 buys1 sellnet +286,018 shares

Szyper Linda MBuy 21,872 · May 14, 2026

Philip Ron MBuy 21,872 · May 14, 2026

Sabater Juan A.Buy 21,872 · May 14, 2026

Recent SEC filings

4 — Insider transaction reportMay 18, 2026

Latest news

Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36 — Benzinga · 1w ago

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? — Yahoo · 1w ago

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase — Yahoo · 1w ago

Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline — Yahoo · 1w ago

Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) — SeekingAlpha · 2w ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Pharmaceuticals →More in Biotechnology →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

Novo Nordisk A/SNVO Eli Lilly and CoLLY Johnson & JohnsonJNJ Merck & Co IncMRK AstraZeneca PLCAZN Pfizer, Inc.PFE

About Harmony Biosciences Holdings, I

Weekly undervalued picks (like HRMY)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.